Henrietta Treyz, Co-Founder at Veda Partners, discussed the implications of renewed U.S.–China trade relations for American agriculture following the recent summit between Presidents Xi Jinping and Donald Trump.

President Trump announced that China will lift its boycott and resume purchasing millions of tons of American soybeans under a new trade truce between the two countries. The agreement offers a much-needed boost for U.S. farmers after months of uncertainty, though the final terms remain unclear.

The Trump administration’s push to lower U.S. drug prices through direct deals with major pharmaceutical companies — including Pfizer, AstraZeneca, and EMD Serono — has drawn scrutiny over its transparency and impact.

President Donald Trump announced a deal with AstraZeneca aimed at lowering drug costs through “Most Favored Nation” pricing — following a similar agreement with Pfizer. Both drugmakers agreed to sell select medications at discounted rates and join the new TrumpRx online platform, offering direct-to-consumer discounts.

Tom Keene highlights the Single Best Idea from the latest Bloomberg Surveillance Radio, featuring insights from Henrietta Treyz and Aakash Doshi.

With just weeks left before the government funding deadline, attention is shifting to how voters might assign blame if lawmakers fail to reach a deal.

Congress faces a looming Sept. 30 funding deadline with just 16 calendar days left — and fewer than half of those scheduled for House and Senate sessions. Anxiety is rising as lawmakers head toward the fiscal year’s end without a full funding plan.

Henrietta Treyz, co-founder of Veda Partners, joined Bloomberg Surveillance to break down the latest policy moves in Washington.

Henrietta explained that a current court case questions the president’s authority under IEEPA to maintain tariffs (like those imposed on India). A ruling from the appeals court could come soon.